Biomedical Engineering Reference
In-Depth Information
111. Choi, C.H.,
., Mechanism of active targeting in solid tumors with
transferrin-containing gold nanoparticles.
et al
Proc Natl Acad Sci USA
,
2010.
107
(3): pp. 1235-1240.
112. Huang, X.,
., A reexamination of active and passive tumor targeting
by using rod-shaped gold nanocrystals and covalently conjugated
peptide ligands.
et al
ACS Nano
, 2010.
4
(10): pp. 5887-5896.
113. Kirpotin, D.B.,
et al
., Antibody targeting of long-circulating lipidic
nanoparticles
does
not
increase
tumor
localization
but
does
increase internalization in animal models.
Cancer Res
, 2006.
66
(13):
pp. 6732-6740.
114. Kappler, M.,
., Increased survivin transcript levels: an independent
negative predictor of survival in soft tissue sarcoma patients.
et al
Int J
Cancer
, 2001.
95
(6): pp. 360-363.
115. Kato, J.,
., Expression of survivin in esophageal cancer: correlation
with the prognosis and response to chemotherapy.
et al
Int J Cancer
, 2001.
(2): pp. 92-95.
116. Asanuma, K.,
95
et al
., Survivin as a radioresistance factor in pancreatic
(11): pp. 1204-1209.
117. Byers, L.A., and J.V. Heymach, Dual targeting of the vascular endothelial
growth factor and epidermal growth factor receptor pathways:
rationale and clinical applications for non-small-cell lung cancer.
cancer.
Jpn J Cancer Res
, 2000.
91
Clin
Lung Cancer
, 2007.
8
(Suppl. 2): pp. S79-85.
118. Dassonville, O.,
., EGFR targeting therapies: monoclonal antibodies
versus tyrosine kinase inhibitors. Similarities and differences.
et al
Crit Rev
(1): pp. 53-61.
119. Sathornsumetee, S., and J.N. Rich, New approaches to primary brain
tumor treatment.
Oncol Hematol
, 2007.
62
(9): pp. 1003-1016.
120. Wong, S.F., Cetuximab: an epidermal growth factor receptor monoclonal
antibody for the treatment of colorectal cancer.
Anticancer Drugs
, 2006.
17
Clin Ther
, 2005.
27
(6):
pp. 684-694.
121. Fan, Q.W., and W.A. Weiss, RNA interference against a glioma-derived
allele of EGFR induces blockade at G2M.
Oncogene
, 2005.
24
(5):
pp. 829-837.
122. Kang, C.S.,
study on the suppressive effect of glioma
cell growth induced by plasmid-based small interference RNA (siRNA)
targeting human epidermal growth factor receptor.
et al
., An
in vitro
J Neurooncol
, 2005.
74
(3): pp. 267-273.
Search WWH ::
Custom Search